ScienceDaily (Apr. 5, 2009) — A quicker, cheaper and more accurate test for deadly Aspergillus fumigatus fungal infections in patients with damaged or suppressed immune systems was described April 2 at the Society for General Microbiology meeting in Harrogate, by Dr Christopher Thornton from the University of Exeter, UK.

Fungal infections are a significant cause of death in patients whose immune systems are suppressed, for example those undergoing bone marrow transplantation or chemotherapy. Infection by breathing in the spores of the fungus Aspergillus fumigatus can cause invasive aspergillosis (IA) that can have a fatality rate approaching 90%. IA is very difficult to detect; doctors need to take tissue samples to see if the fungus is growing in the body.

As this is often not possible in very sick patients, tests that detect signature molecules of the fungus in patient's serum are used. These existing tests are costly, and require expertise and sophisticated laboratory facilities to run. They also cannot distinguish between molecules from the Aspergillus fungus and similar molecules from antibiotics and foodstuffs, and even certain bacteria.

Dr Thornton and colleagues have developed a test for IA using technology similar to that used in home pregnancy tests. The test uses a monoclonal antibody that binds to a glycoprotein antigen secreted specifically by Aspergillus species. It does not give a reaction with any other clinically important fungi. It only takes 15 minutes to perform, making it quicker and less costly than conventional laboratory-based tests.

"Because our test is user-friendly it can be used to diagnose IA at the 'point-of-care' for patients, said Dr Thornton, "it can be used to provide routine monitoring of patients at high-risk for the disease, such as bone marrow transplant recipients and leukaemia patients. We are currently working with a multinational clinical diagnostics company to develop a commercial version of the device."

Story Source:

Adapted from materials provided by Society for General Microbiology, via EurekAlert!, a service of AAAS.

Related Stories

Scientists Develop Fungus-Fighting Vaccine (Sep. 5, 2005) — A group of scientists in Italy have developed a vaccine with the potential to protect against fungal pathogens that commonly infect humans, according to a study by Torosantucci and colleagues in the ...  > read more

European Research Effort Tackles Dangerous Mould (Sep. 24, 2008) — Ubiquitous fungus Aspergillus fumigatus poses an increasing threat to patients with compromised immune systems. The European Science Foundation has launched a new Research Networking Programme, ...  > read more

Gene That Governs Toxin Production In Deadly Mold Found (Apr. 13, 2007) — For the growing number of people with diminished immune systems -- cancer patients, transplant recipients, those with HIV/AIDS -- infection by a ubiquitous mold known as Aspergillus fumigatus can be ...  > read more

Pillows: A Hot Bed Of Fungal Spores (Oct. 15, 2005) — Researchers at The University of Manchester funded by the Fungal Research Trust have discovered millions of fungal spores right under our noses -- in our pillows. Aspergillus fumigatus, the species ...  > read more

Search ScienceDaily

Beating Bone Marrow Cancer